Summit Therapeutics
Zealand wins in obesity, Genmab hits first-line DLBCL and Oncopeptides crosses the blood-brain barrier – the Nordic Pulse | 2026:41
Egetis wins FDA approval, Indices retreat across the board – the Nordic Pulse | 2026:40
AstraZeneca köper in sig i Summit – det är bara början
AstraZeneca lägger två miljarder dollar på tolv procent...
Krönika
A quarter of billion-euro licences, a Novo comeback and a flat Nordic index – the State of Nordic BioPharma | 2026:Q3
Analytics